Cleared Traditional

K201308 - Axonpen, Axonmonitor, Axonbox, Tablet
(FDA 510(k) Clearance)

Nov 2020
Decision
196d
Days
Class 2
Risk

K201308 is an FDA 510(k) clearance for the Axonpen, Axonmonitor, Axonbox, Tablet. This device is classified as a Endoscope, Neurological (Class II - Special Controls, product code GWG).

Submitted by Clearmind Biomedical (Taipei, TW). The FDA issued a Cleared decision on November 27, 2020, 196 days after receiving the submission on May 15, 2020.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.1480. If The Device Is Reusable, Validated Reprocessing Instructions And Reprocessing Validation Data For This Device Type Must Be Included In A 510(k) Submission (82 Fr 26807, Available At Https://www.gpo.gov/fdsys/pkg/fr-2017-06-09/pdf/2017-12007.pdf)..

Submission Details

510(k) Number K201308 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 15, 2020
Decision Date November 27, 2020
Days to Decision 196 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code GWG — Endoscope, Neurological
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.1480
Definition If The Device Is Reusable, Validated Reprocessing Instructions And Reprocessing Validation Data For This Device Type Must Be Included In A 510(k) Submission (82 Fr 26807, Available At Https://www.gpo.gov/fdsys/pkg/fr-2017-06-09/pdf/2017-12007.pdf).

Similar Devices — GWG Endoscope, Neurological

All 90
HJY VisualNext 3D Endoscopic Vision System
K243429 · Hjy Smart Medical Device Co., Ltd. · May 2025
AURORA? Surgiscope? System (ASX15/60); AURORA? Surgiscope? System (ASX15/80)
K250752 · Integra LifeSciences Corporation · Apr 2025
cCeLL - In vivo
K233391 · VPIX Medical, Inc. · Aug 2024
Digital ClarusScope System, Digital NeuroPEN System
K223615 · Clarus Medical, LLC · Nov 2023
Aurora Surgiscope System
K232618 · Rebound Therapeutics Corporation · Oct 2023
Neuroblade System
K230125 · Clearmind Biomedical · Oct 2023